Workflow
博济医药拟用不超2.5亿元闲置自有资金进行现金管理

Core Viewpoint - The company has announced the use of idle funds for cash management, aiming to enhance fund utilization efficiency while ensuring operational needs and safety [1][3]. Group 1: Investment Details - The company plans to use up to RMB 250 million of idle self-owned funds for cash management, with the funds being able to roll over within a 12-month period [1]. - The investment objective is to achieve capital preservation and appreciation while safeguarding shareholder interests [1]. - The selected investment products will be high in safety, good in liquidity, and controllable in risk, ensuring no impact on the company's normal operational funds [1]. Group 2: Risk Analysis and Control - The company acknowledges that financial market fluctuations can impact investment outcomes, and thus, it will adhere to prudent investment principles [2]. - Risk control measures include selecting reputable financial institutions and products, conducting pre-investment risk assessments, and maintaining regular audits and oversight [2]. - The internal audit department will supervise fund usage and storage, with independent directors and the audit committee having the authority to monitor and review [2]. Group 3: Impact on the Company - The cash management initiative is expected to improve fund utilization efficiency and generate investment returns, ultimately benefiting the company and its shareholders [3]. - Both the board and the supervisory committee have expressed support for the cash management plan, confirming its legality and alignment with shareholder interests [3]. - The sponsor institution has verified that the necessary review procedures have been followed and will continue to monitor the fund usage [3].